128 related articles for article (PubMed ID: 18679651)
1. [Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors].
Serth J; Tezval H; Peters I; Atschekzei F; Rehmet K; Jurk S; Albrecht K; Kuczyk MA; Merseburger AS
Urologe A; 2008 Sep; 47(9):1117-8, 1120-1. PubMed ID: 18679651
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
3. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
5. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
[TBL] [Abstract][Full Text] [Related]
7. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994
[TBL] [Abstract][Full Text] [Related]
8. Quantitative methylation profiling of renal tumors and the discovery of a new generation of molecular markers.
Jerónimo C
Future Oncol; 2005 Apr; 1(2):197-200. PubMed ID: 16555990
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
10. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984
[TBL] [Abstract][Full Text] [Related]
11. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.
Yu GS; Lai CY; Xu Y; Bu CF; Su ZX
Asian Pac J Cancer Prev; 2015; 16(11):4665-9. PubMed ID: 26107221
[TBL] [Abstract][Full Text] [Related]
14. Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma.
Kawai Y; Sakano S; Suehiro Y; Okada T; Korenaga Y; Hara T; Naito K; Matsuyama H; Hinoda Y
Ann Oncol; 2010 Aug; 21(8):1612-1617. PubMed ID: 20038516
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.
Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L
Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas.
Yoon JH; Dammann R; Pfeifer GP
Int J Cancer; 2001 Oct; 94(2):212-7. PubMed ID: 11668500
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues.
Aitchison A; Warren A; Neal D; Rabbitts P
Prostate; 2007 May; 67(6):638-44. PubMed ID: 17342751
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
20. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]